Immunologic studies of human breast cancer. I. Serum reactivity against a lymphoid cell line (Belev) derived from a breast cancer patient as detected by complement-fixation test.

Immunologic studies of human breast cancer. I. Serum reactivity against a lymphoid cell line (Belev) derived from a breast cancer patient as detected by complement-fixation test.